AGÕæÈ˹ٷ½

STOCK TITAN

[8-K] SiriusPoint Ltd. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

AACG’s amended Form 6-K clarifies pricing details for a previously disclosed, non-binding term sheet signed on 1 Aug 2025 with Baby BTC Strategic Capital Ltd. ("Baby Capital").

  • Share issuance: Up to 68,728,522 common shares (par US$0.01) at an implied US$0.8730 per ADS (US$0.4365 per share) for gross proceeds of ≈US$30 million.
  • Warrant: Two-year warrant exercisable at US$1.7460 per ADS (US$0.8730 per share) for up to US$70 million of additional equity.
  • Change of control: Completion of the initial issuance would give Baby Capital control of AACG and the right to appoint three directors.
  • Use of proceeds: Primarily to purchase BABY Token; remaining funds for Bitcoin purchases and collaboration with Babylon Foundation on BTC staking and DeFi applications.
  • Next steps & uncertainty: Parties aim to sign a definitive agreement within two months; transactions remain contingent on negotiation, board approval and other conditions—no assurance of closing.

The filing amends the original 6-K only to specify the ADS-level purchase and exercise prices; it contains no new financial results. Investors face capital infusion upside but also dilution, crypto-related deployment risk and deal execution risk.

Il modulo 6-K modificato di AACG chiarisce i dettagli di prezzo relativi a un term sheet non vincolante precedentemente comunicato, firmato il 1° agosto 2025 con Baby BTC Strategic Capital Ltd. ("Baby Capital").

  • Emissione di azioni: Fino a 68.728.522 azioni ordinarie (valore nominale US$0,01) a un prezzo implicito di US$0,8730 per ADS (US$0,4365 per azione) per un ricavo lordo di circa US$30 milioni.
  • Warrant: Warrant biennale esercitabile a US$1,7460 per ADS (US$0,8730 per azione) per un massimo di US$70 milioni di capitale aggiuntivo.
  • Change of control: Il completamento dell’emissione iniziale conferirebbe a Baby Capital il controllo di AACG e il diritto di nominare tre amministratori.
  • Utilizzo dei proventi: Principalmente per l’acquisto di BABY Token; i fondi residui saranno destinati all’acquisto di Bitcoin e alla collaborazione con Babylon Foundation su staking BTC e applicazioni DeFi.
  • Prossimi passi e incertezze: Le parti puntano a firmare un accordo definitivo entro due mesi; le transazioni restano soggette a negoziazione, approvazione del consiglio e altre condizioni, senza garanzia di conclusione.

Il deposito modifica il 6-K originale soltanto per specificare i prezzi di acquisto e di esercizio a livello ADS; non contiene nuovi risultati finanziari. Gli investitori affrontano un potenziale aumento di capitale ma anche diluzione, rischi legati all’impiego in criptovalute e rischi di esecuzione dell’accordo.

El Formulario 6-K enmendado de AACG aclara los detalles de precios para una hoja de términos no vinculante previamente divulgada, firmada el 1 de agosto de 2025 con Baby BTC Strategic Capital Ltd. ("Baby Capital").

  • Emisión de acciones: Hasta 68.728.522 acciones ordinarias (valor nominal US$0,01) a un precio implícito de US$0,8730 por ADS (US$0,4365 por acción) para ingresos brutos de aproximadamente US$30 millones.
  • Warrant: Warrant a dos años ejercitable a US$1,7460 por ADS (US$0,8730 por acción) por hasta US$70 millones adicionales en capital.
  • Cambio de control: La finalización de la emisión inicial otorgaría a Baby Capital el control de AACG y el derecho a nombrar tres directores.
  • Uso de los fondos: Principalmente para comprar BABY Token; los fondos restantes para la compra de Bitcoin y colaboración con Babylon Foundation en staking de BTC y aplicaciones DeFi.
  • Próximos pasos e incertidumbre: Las partes buscan firmar un acuerdo definitivo en dos meses; las transacciones dependen de negociaciones, aprobación del consejo y otras condiciones, sin garantía de cierre.

La presentación enmienda el 6-K original solo para especificar los precios de compra y ejercicio a nivel ADS; no contiene nuevos resultados financieros. Los inversores enfrentan un potencial aumento de capital pero también dilución, riesgos relacionados con criptomonedas y riesgos en la ejecución del acuerdo.

AACGì� 수정ë� Form 6-KëŠ� 2025ë…� 8ì›� 1ì� Baby BTC Strategic Capital Ltd.("Baby Capital")와 ì²´ê²°í•� 비구ì†ì  ì¡°ê±´ì„�ì� ê°€ê²� 세부사항ì� 명확íž� 합니ë‹�.

  • ì£¼ì‹ ë°œí–‰: 최대 68,728,522 보통ì£�(ì•¡ë©´ê°€ 미화 0.01달러)ë¥� ADSë‹� 미화 0.8730달러(주당 미화 0.4365달러)ë¡� 발행하여 ì´� ì•� 3,000ë§� 달러ì� ì´ìˆ˜ìµì„ 기대합니ë‹�.
  • 워런íŠ�: 2ë…� 만기 워런트로 ADSë‹� 미화 1.7460달러(주당 미화 0.8730달러)ì—� 행사 가능하ë©� 최대 7,000ë§� 달러 추가 ìžë³¸ 조달 ê°€ëŠ�.
  • 지배권 ë³€ê²�: 초기 ì£¼ì‹ ë°œí–‰ 완료 ì‹� Baby Capitalì� AACGì� 지배권ì� 확보하고 ì´ì‚¬ 3ëª…ì„ ì„ ìž„í•� 권리ë¥� 가집니ë‹�.
  • ìžê¸ˆ 사용ì²�: 주로 BABY í† í° êµ¬ë§¤ì—� 사용하며, 나머지 ìžê¸ˆì€ ë¹„íŠ¸ì½”ì¸ êµ¬ë§¤ ë°� Babylon Foundationê³¼ì˜ BTC 스테ì´í‚¹ê³� DeFi 애플리케ì´ì…˜ 협력ì—� 투입ë©ë‹ˆë‹�.
  • 향후 ê³„íš ë°� 불확실성: ì–‘ì¸¡ì€ 2개월 ë‚´ì— ìµœì¢… 계약 ì²´ê²°ì� 목표ë¡� 하며, 거래ëŠ� 협ìƒ, ì´ì‚¬íš� ìŠ¹ì¸ ë°� 기타 ì¡°ê±´ì—� ë”°ë¼ ë‹¬ë¼ì§€ë©� 완료가 보장ë˜ì§€ 않습니다.

ì´ë²ˆ ì œì¶œì€ ì›ëž˜ 6-K 문서ì—서 ADS 단위ì� 구매 ë°� 행사 가격만 명시하ë„ë¡� 수정í•� 것으ë¡�, 새로ìš� 재무 ê²°ê³¼ëŠ� í¬í•¨í•˜ì§€ 않습니다. 투ìžìžë“¤ì€ ìžë³¸ 유입ì� 잠재ì � ì´ì ê³� 함께 í¬ì„, 암호화í ê´€ë � íˆ¬ìž ìœ„í—˜, 거래 실행 위험ë� ê°ìˆ˜í•´ì•¼ 합니ë‹�.

Le formulaire 6-K modifié d’AACG précise les détails de tarification »å’u²Ô±ð lettre d’intention non contraignante précédemment annoncée, signée le 1er août 2025 avec Baby BTC Strategic Capital Ltd. ("Baby Capital").

  • Émission d’actions : Jusqu’Ã� 68 728 522 actions ordinaires (valeur nominale 0,01 $ US) à un prix implicite de 0,8730 $ US par ADS (0,4365 $ US par action) pour un produit brut d’environ 30 millions $ US.
  • Warrant : Warrant de deux ans exerçable à 1,7460 $ US par ADS (0,8730 $ US par action) pour un capital additionnel pouvant atteindre 70 millions $ US.
  • Changement de contrôle : La réalisation de l’émission initiale donnerait à Baby Capital le contrôle d’AACG et le droit de nommer trois administrateurs.
  • Utilisation des fonds : Principalement pour l’achat de BABY Token ; les fonds restants seront utilisés pour des achats de Bitcoin et une collaboration avec la Babylon Foundation sur le staking BTC et les applications DeFi.
  • Étapes suivantes et incertitudes : Les parties visent à signer un accord définitif dans les deux mois ; les transactions restent soumises à la négociation, à l’approbation du conseil et à d’autres conditions, sans garantie de conclusion.

Le dépôt modifie uniquement le 6-K original pour préciser les prix d’achat et d’exercice au niveau ADS ; il ne contient aucun nouveau résultat financier. Les investisseurs font face à une opportunité d’injection de capital mais aussi à une dilution, des risques liés aux cryptomonnaies et des risques d’exécution de l’accord.

AACGs geändertes Formular 6-K klärt die Preisdaten für ein zuvor bekanntgegebenes, unverbindliches Term Sheet, das am 1. August 2025 mit Baby BTC Strategic Capital Ltd. ("Baby Capital") unterzeichnet wurde.

  • Aktienausgabe: Bis zu 68.728.522 Stammaktien (Nennwert 0,01 US$) zu einem impliziten Preis von 0,8730 US$ pro ADS (0,4365 US$ pro Aktie) für Bruttoerlöse von ca. 30 Millionen US$.
  • Warrant: Zweijahres-Warrant, ausübbar zu 1,7460 US$ pro ADS (0,8730 US$ pro Aktie) für bis zu 70 Millionen US$ zusätzliches Eigenkapital.
  • Kontrollwechsel: Der Abschluss der Erstemission würde Baby Capital die Kontrolle über AACG verschaffen und das Recht, drei Direktoren zu ernennen.
  • Verwendung der Erlöse: Hauptsächlich zum Kauf von BABY Token; verbleibende Mittel für Bitcoin-Käufe und Zusammenarbeit mit der Babylon Foundation bei BTC-Staking und DeFi-Anwendungen.
  • Nächste Schritte & Unsicherheiten: Die Parteien streben an, innerhalb von zwei Monaten eine endgültige Vereinbarung zu unterzeichnen; die Transaktionen hängen von Verhandlungen, Vorstandsgenehmigung und weiteren Bedingungen ab â€� kein Abschluss garantiert.

Die Einreichung ändert das ursprüngliche 6-K nur, um die Kauf- und Ausübungspreise auf ADS-Ebene anzugeben; es enthält keine neuen Finanzergebnisse. Investoren stehen Kapitalzuflusschancen gegenüber, aber auch Verwässerung, Krypto-bezogene Einsatzrisiken und Risiken bei der Deal-Durchführung.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Potential US$30-100 M capital but highly dilutive, crypto-linked deployment raises risk.

The term sheet could inject much-needed cash into AACG, whose market cap is ~US$20 M, but would roughly triple the share count on closing and far more if the warrant is exercised. The pricing represents a modest 3 % discount to the 10-day VWAP, limiting immediate arbitrage, yet control shifts to Baby Capital. Planned use of proceeds—buying BABY Token and Bitcoin staking—diverges from AACG’s core education franchise, introducing volatility and regulatory uncertainty. Deal is non-binding; failure to sign a definitive agreement would leave AACG without the expected funds. Overall impact skews negative: dilution and strategic drift outweigh cash infusion upside.

TL;DR: Change-of-control via private placement raises governance and minority-holder concerns.

Baby Capital would gain control and three board seats without a shareholder vote, typical in many offshore structures but contentious for U.S. investors. The warrant could lift Baby Capital’s ownership well above 50 %, entrenching influence. Absence of board-level special committee review and lack of fairness opinion (not mentioned) heighten related-party and valuation risks. Deploying proceeds into crypto assets rather than the core education business may breach fiduciary norms if returns disappoint. Minority protection mechanisms are not disclosed, signaling governance risk.

Il modulo 6-K modificato di AACG chiarisce i dettagli di prezzo relativi a un term sheet non vincolante precedentemente comunicato, firmato il 1° agosto 2025 con Baby BTC Strategic Capital Ltd. ("Baby Capital").

  • Emissione di azioni: Fino a 68.728.522 azioni ordinarie (valore nominale US$0,01) a un prezzo implicito di US$0,8730 per ADS (US$0,4365 per azione) per un ricavo lordo di circa US$30 milioni.
  • Warrant: Warrant biennale esercitabile a US$1,7460 per ADS (US$0,8730 per azione) per un massimo di US$70 milioni di capitale aggiuntivo.
  • Change of control: Il completamento dell’emissione iniziale conferirebbe a Baby Capital il controllo di AACG e il diritto di nominare tre amministratori.
  • Utilizzo dei proventi: Principalmente per l’acquisto di BABY Token; i fondi residui saranno destinati all’acquisto di Bitcoin e alla collaborazione con Babylon Foundation su staking BTC e applicazioni DeFi.
  • Prossimi passi e incertezze: Le parti puntano a firmare un accordo definitivo entro due mesi; le transazioni restano soggette a negoziazione, approvazione del consiglio e altre condizioni, senza garanzia di conclusione.

Il deposito modifica il 6-K originale soltanto per specificare i prezzi di acquisto e di esercizio a livello ADS; non contiene nuovi risultati finanziari. Gli investitori affrontano un potenziale aumento di capitale ma anche diluzione, rischi legati all’impiego in criptovalute e rischi di esecuzione dell’accordo.

El Formulario 6-K enmendado de AACG aclara los detalles de precios para una hoja de términos no vinculante previamente divulgada, firmada el 1 de agosto de 2025 con Baby BTC Strategic Capital Ltd. ("Baby Capital").

  • Emisión de acciones: Hasta 68.728.522 acciones ordinarias (valor nominal US$0,01) a un precio implícito de US$0,8730 por ADS (US$0,4365 por acción) para ingresos brutos de aproximadamente US$30 millones.
  • Warrant: Warrant a dos años ejercitable a US$1,7460 por ADS (US$0,8730 por acción) por hasta US$70 millones adicionales en capital.
  • Cambio de control: La finalización de la emisión inicial otorgaría a Baby Capital el control de AACG y el derecho a nombrar tres directores.
  • Uso de los fondos: Principalmente para comprar BABY Token; los fondos restantes para la compra de Bitcoin y colaboración con Babylon Foundation en staking de BTC y aplicaciones DeFi.
  • Próximos pasos e incertidumbre: Las partes buscan firmar un acuerdo definitivo en dos meses; las transacciones dependen de negociaciones, aprobación del consejo y otras condiciones, sin garantía de cierre.

La presentación enmienda el 6-K original solo para especificar los precios de compra y ejercicio a nivel ADS; no contiene nuevos resultados financieros. Los inversores enfrentan un potencial aumento de capital pero también dilución, riesgos relacionados con criptomonedas y riesgos en la ejecución del acuerdo.

AACGì� 수정ë� Form 6-KëŠ� 2025ë…� 8ì›� 1ì� Baby BTC Strategic Capital Ltd.("Baby Capital")와 ì²´ê²°í•� 비구ì†ì  ì¡°ê±´ì„�ì� ê°€ê²� 세부사항ì� 명확íž� 합니ë‹�.

  • ì£¼ì‹ ë°œí–‰: 최대 68,728,522 보통ì£�(ì•¡ë©´ê°€ 미화 0.01달러)ë¥� ADSë‹� 미화 0.8730달러(주당 미화 0.4365달러)ë¡� 발행하여 ì´� ì•� 3,000ë§� 달러ì� ì´ìˆ˜ìµì„ 기대합니ë‹�.
  • 워런íŠ�: 2ë…� 만기 워런트로 ADSë‹� 미화 1.7460달러(주당 미화 0.8730달러)ì—� 행사 가능하ë©� 최대 7,000ë§� 달러 추가 ìžë³¸ 조달 ê°€ëŠ�.
  • 지배권 ë³€ê²�: 초기 ì£¼ì‹ ë°œí–‰ 완료 ì‹� Baby Capitalì� AACGì� 지배권ì� 확보하고 ì´ì‚¬ 3ëª…ì„ ì„ ìž„í•� 권리ë¥� 가집니ë‹�.
  • ìžê¸ˆ 사용ì²�: 주로 BABY í† í° êµ¬ë§¤ì—� 사용하며, 나머지 ìžê¸ˆì€ ë¹„íŠ¸ì½”ì¸ êµ¬ë§¤ ë°� Babylon Foundationê³¼ì˜ BTC 스테ì´í‚¹ê³� DeFi 애플리케ì´ì…˜ 협력ì—� 투입ë©ë‹ˆë‹�.
  • 향후 ê³„íš ë°� 불확실성: ì–‘ì¸¡ì€ 2개월 ë‚´ì— ìµœì¢… 계약 ì²´ê²°ì� 목표ë¡� 하며, 거래ëŠ� 협ìƒ, ì´ì‚¬íš� ìŠ¹ì¸ ë°� 기타 ì¡°ê±´ì—� ë”°ë¼ ë‹¬ë¼ì§€ë©� 완료가 보장ë˜ì§€ 않습니다.

ì´ë²ˆ ì œì¶œì€ ì›ëž˜ 6-K 문서ì—서 ADS 단위ì� 구매 ë°� 행사 가격만 명시하ë„ë¡� 수정í•� 것으ë¡�, 새로ìš� 재무 ê²°ê³¼ëŠ� í¬í•¨í•˜ì§€ 않습니다. 투ìžìžë“¤ì€ ìžë³¸ 유입ì� 잠재ì � ì´ì ê³� 함께 í¬ì„, 암호화í ê´€ë � íˆ¬ìž ìœ„í—˜, 거래 실행 위험ë� ê°ìˆ˜í•´ì•¼ 합니ë‹�.

Le formulaire 6-K modifié d’AACG précise les détails de tarification »å’u²Ô±ð lettre d’intention non contraignante précédemment annoncée, signée le 1er août 2025 avec Baby BTC Strategic Capital Ltd. ("Baby Capital").

  • Émission d’actions : Jusqu’Ã� 68 728 522 actions ordinaires (valeur nominale 0,01 $ US) à un prix implicite de 0,8730 $ US par ADS (0,4365 $ US par action) pour un produit brut d’environ 30 millions $ US.
  • Warrant : Warrant de deux ans exerçable à 1,7460 $ US par ADS (0,8730 $ US par action) pour un capital additionnel pouvant atteindre 70 millions $ US.
  • Changement de contrôle : La réalisation de l’émission initiale donnerait à Baby Capital le contrôle d’AACG et le droit de nommer trois administrateurs.
  • Utilisation des fonds : Principalement pour l’achat de BABY Token ; les fonds restants seront utilisés pour des achats de Bitcoin et une collaboration avec la Babylon Foundation sur le staking BTC et les applications DeFi.
  • Étapes suivantes et incertitudes : Les parties visent à signer un accord définitif dans les deux mois ; les transactions restent soumises à la négociation, à l’approbation du conseil et à d’autres conditions, sans garantie de conclusion.

Le dépôt modifie uniquement le 6-K original pour préciser les prix d’achat et d’exercice au niveau ADS ; il ne contient aucun nouveau résultat financier. Les investisseurs font face à une opportunité d’injection de capital mais aussi à une dilution, des risques liés aux cryptomonnaies et des risques d’exécution de l’accord.

AACGs geändertes Formular 6-K klärt die Preisdaten für ein zuvor bekanntgegebenes, unverbindliches Term Sheet, das am 1. August 2025 mit Baby BTC Strategic Capital Ltd. ("Baby Capital") unterzeichnet wurde.

  • Aktienausgabe: Bis zu 68.728.522 Stammaktien (Nennwert 0,01 US$) zu einem impliziten Preis von 0,8730 US$ pro ADS (0,4365 US$ pro Aktie) für Bruttoerlöse von ca. 30 Millionen US$.
  • Warrant: Zweijahres-Warrant, ausübbar zu 1,7460 US$ pro ADS (0,8730 US$ pro Aktie) für bis zu 70 Millionen US$ zusätzliches Eigenkapital.
  • Kontrollwechsel: Der Abschluss der Erstemission würde Baby Capital die Kontrolle über AACG verschaffen und das Recht, drei Direktoren zu ernennen.
  • Verwendung der Erlöse: Hauptsächlich zum Kauf von BABY Token; verbleibende Mittel für Bitcoin-Käufe und Zusammenarbeit mit der Babylon Foundation bei BTC-Staking und DeFi-Anwendungen.
  • Nächste Schritte & Unsicherheiten: Die Parteien streben an, innerhalb von zwei Monaten eine endgültige Vereinbarung zu unterzeichnen; die Transaktionen hängen von Verhandlungen, Vorstandsgenehmigung und weiteren Bedingungen ab â€� kein Abschluss garantiert.

Die Einreichung ändert das ursprüngliche 6-K nur, um die Kauf- und Ausübungspreise auf ADS-Ebene anzugeben; es enthält keine neuen Finanzergebnisse. Investoren stehen Kapitalzuflusschancen gegenüber, aber auch Verwässerung, Krypto-bezogene Einsatzrisiken und Risiken bei der Deal-Durchführung.

0001576018false00015760182025-08-042025-08-040001576018us-gaap:CommonStockMember2025-08-042025-08-040001576018tpre:A800ResettableFixedRatePreferenceSharesSeriesBMember2025-08-042025-08-04

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): August 4, 2025 (August 4, 2025)
 
 SIRIUSPOINT LTD.
(Exact name of registrant as specified in its charter)
  
Bermuda 001-36052 98-1599372
(State or other jurisdiction
of incorporation)
 (Commission
File Number)
 (I.R.S. Employer
Identification No.)
Point Building
3 Waterloo Lane
Pembroke HM 08 Bermuda
(Address of principal executive offices and Zip Code)
Registrant’s telephone number, including area code: +1 441 542-3300
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Common Shares, $0.10 par valueSPNTNew York Stock Exchange
8.00% Resettable Fixed Rate Preference Shares,
 Series B, $0.10 par value,
$25.00 liquidation preference per share
SPNT PBNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 2.02Results of Operations and Financial Condition.
On August 4, 2025, SiriusPoint Ltd. issued a press release reporting its financial results for the second quarter ended June 30, 2025 attached hereto as Exhibit 99.1.
The information contained in this Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished pursuant to this Item 2.02. This information shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, or incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 7.01Regulation FD Disclosure.
On August 4, 2025, SiriusPoint Ltd. made available to investors its second quarter financial supplement attached hereto as Exhibit 99.2, and slide presentation attached hereto as Exhibit 99.3 by SiriusPoint Ltd. in presentations to investors.
The information contained in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.2 and Exhibit 99.3 attached hereto, are being furnished pursuant to this Item 7.01. This information shall not deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section, or incorporated by reference into any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 8.01    Other Events.
On July 30, 2025, the Audit Commitee of the Board of Directors of SiriusPoint Ltd. approved a quarterly cash dividend of $0.50 per share on its 8.00% Resettable Fixed Rate Preference Shares, Series B, $0.10 par value, $25.00 liquidation preference per share payable on August 29, 2025 to Series B shareholders of record as of August 14, 2025. A copy of the press release is attached hereto as Exhibit 99.4.
Item 9.01Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No.
  Description
99.1  
Press Release dated August 4, 2025, announcing the earnings of SiriusPoint Ltd. for the Second Quarter Ended June 30, 2025.
99.2
Second Quarter Ended June 30, 2025 Financial Supplement.
99.3
SiriusPoint Ltd. Presentation to Investors, dated August 4, 2025.
99.4
Press Release dated August 4, 2025, announcing the quarterly dividend on the 8.00% Resettable Fixed Rate Preference Shares, Series B, $0.10 par value.
104Cover Page Interactive Data File (embedded within the Inline XBRL document).




SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: August 4, 2025 
/s/ Scott Egan
 Name:
Scott Egan
 Title:
Chief Executive Officer




FAQ

What is the share price AACG will receive under the Baby Capital deal?

AACG will issue shares at an equivalent US$0.8730 per ADS (two common shares).

How much cash could AACG raise from the transaction?

The initial share issuance totals up to US$30 million; the two-year warrant could bring an additional US$70 million on exercise.

Will Baby Capital control AACG after the deal?

Yes. Upon closing of the share issuance, Baby Capital is expected to obtain control and appoint three directors to AACG’s board.

How will AACG use the proceeds?

Proceeds are slated mainly to purchase BABY Token; any remainder will buy Bitcoin and support BTC staking projects with Babylon Foundation.

Is the agreement definitive?

No. The term sheet is non-binding; parties aim to sign a definitive agreement within two months, but closing is uncertain.

What is the warrant exercise price?

The warrant can be exercised at US$1.7460 per ADS (US$0.8730 per common share) within two years of issuance.
Siriuspoint Ltd

NYSE:SPNT

SPNT Rankings

SPNT Latest News

SPNT Latest SEC Filings

SPNT Stock Data

2.28B
103.05M
11.44%
87.92%
1.91%
Insurance - Reinsurance
Fire, Marine & Casualty Insurance
Bermuda
NEW YORK